Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20050119726 A1
Publication typeApplication
Application numberUS 11/003,060
Publication date2 Jun 2005
Filing date3 Dec 2004
Priority date24 Aug 1989
Also published asUS6344053, US6663661, US6827733, US20020049488, US20040064180
Publication number003060, 11003060, US 2005/0119726 A1, US 2005/119726 A1, US 20050119726 A1, US 20050119726A1, US 2005119726 A1, US 2005119726A1, US-A1-20050119726, US-A1-2005119726, US2005/0119726A1, US2005/119726A1, US20050119726 A1, US20050119726A1, US2005119726 A1, US2005119726A1
InventorsMichael Boneau
Original AssigneeMedtronic Vascular, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Endovascular support device and method
US 20050119726 A1
Abstract
An endovascular support device for treatment of chronic restenosis or other vascular narrowing is disclosed together with a method of manufacture and a method for delivering a plurality of such devices to an affected area of a vessel. In a preferred embodiment, the endovascular support device comprises a unitary wire-like structure configured to form a plurality of upper and lower peaks which may be compressed for delivery to an affected area of a coronary or peripheral vessel in a human, and then expanded to maintain a passageway through the vessel.
Images(4)
Previous page
Next page
Claims(6)
1-3. (canceled)
4. An intraluminal support device, comprising:
A plurality of balloon expandable rings parallel and adjacently aligned, each ring comprising axial turns, wherein at least one of the axial turns facing a first direction and at least one of the axial turns facing a second direction are not connected to an adjacently aligned expandable ring and have an ellipsoidal cross-section.
5. The support device of claim 4 wherein each of the plurality of straight portions is disposed between a pair of axial turns.
6. The support device of claim 5 wherein the straight portions extend from a first axial turn to a second axial turn.
7. wherein the rings are made of a metal alloy.
8. wherein the rings are expanded from a first expandable radius to a second expanded radius.
Description
    FIELD OF THE INVENTION
  • [0001]
    The present invention relates generally to medical devices, and particularly relates to implantable devices for treating narrowing of coronary or peripheral vessels in humans.
  • BACKGROUND OF THE INVENTION
  • [0002]
    Cardiovascular disease, including atherosclerosis, is the leading cause of death in the U.S. The medical community has developed a number of methods for treating coronary heart disease, some of which are specifically designed to treat the complications resulting from atherosclerosis and other forms of coronary arterial narrowing.
  • [0003]
    The most impelling development in the past decade for treating atherosclerosis and other forms of coronary narrowing is percutaneous transluminal coronary angioplasty, hereinafter referred to simply as “angioplasty” or “PTCA”. The objective in angioplasty is to enlarge the lumen of the affected coronary artery by radial hydraulic expansion. The procedure is accomplished by inflating a balloon within the narrowed lumen of the coronary artery. Radial expansion of the coronary artery occurs in several different dimensions and is related to the nature of the plaque. Soft, fatty plaque deposits are flattened by the balloon and hardened deposits are cracked and split to enlarge the lumen. The wall of the artery itself is also stretched when the balloon is inflated.
  • [0004]
    PTCA is performed as follows: A thin-walled, hollow guiding catheter is typically introduced into the body via a relatively larger vessel, such as the femoral artery in the groin area or the brachial artery in the arm. Access to the femoral artery is achieved by introducing a large bore needle directly into the femoral artery, a procedure known as the Seldinger Technique. Once access to the femoral artery is achieved, a short hollow sheath is inserted to maintain a passageway during PTCA. The flexible guiding catheter, which is typically polymer coated, and lined with Teflon, is inserted through the sheath into the femoral artery. The guiding catheter is advanced through the femoral artery into the iliac artery and into the ascending aorta. Further advancement of the flexible catheter involves the negotiation of an approximately 180 degree turn through the aortic arch to allow the guiding catheter to descend into the aortic cusp where entry may be gained to either the left or the right coronary artery, as desired.
  • [0005]
    After the guiding catheter is advanced to the ostium of the coronary artery to be treated by PTCA, a flexible guidewire is inserted into the guiding catheter through a balloon and advanced to the area to be treated. The guidewire provides the necessary steerability for lesion passage. The guidewire is advanced across the lesion, or “wires” the lesion, in preparation for the advancement of a polyethylene, polyvinyl chloride, polyolefin, or other suitable substance balloon catheter across the guide wire. The use of the relatively rigid guide wire is necessary to advance the catheter through the narrowed lumen of the artery and to direct the balloon, which is typically quite flexible, across the lesion. Radiopaque markers in the balloon segment of the catheter facilitate positioning across the lesion. The balloon catheter is then inflated with the contrast material to permit fluoroscopic viewing during treatment. The balloon is alternately inflated and deflated until the lumen of the artery is satisfactorily enlarged.
  • [0006]
    Unfortunately, while the affected artery can be enlarged, in some instances the vessel restenosis chronically, or closes down acutely, negating the positive effect of the angioplasty procedure. In the past, such restenosis has frequently necessitated repeat PTCA or open heart surgery. While such restenosis does not occur in the majority of cases, it occurs frequently enough that such complications comprise a significant percentage of the overall failures of the PTCA procedure, for example, twenty-five to thirty-five percent of such failures.
  • [0007]
    To lessen the risk of restenosis, various devices have been proposed for mechanically keeping the affected vessel open after completion of the angioplasty procedure. Such mechanical endoprosthetic devices, which are generally referred to as stents, are typically inserted into the vessel, positioned across the lesion, and then expanded to keep the passageway clear. Effectively, the stent overcomes the natural tendency of the vessel walls of some patients to close back down, thereby maintaining a more normal flow of blood through that vessel than would be possible if the stent were not in place.
  • [0008]
    Various types of stents have been proposed, although to date none has proven satisfactory. One proposed stent involves a tube of stainless wire braid. During insertion, the tube is positioned along a delivery device, such as a catheter, in extended form, making the tube diameter as small as possible. When the stent is positioned across the lesion, it is expanded, causing the length of the tube to contract and the diameter to expand. Depending on the materials used in the construction of the stent, the tube maintains the new shape either through mechanical force or otherwise. For example, one such stent is a self-expanding stainless steel wire braid. Other forms of stents include various types tubular metallic cylinders expanded by balloon dilatation. One such device is referred to as the Palmaz stent, discussed further below.
  • [0009]
    Another form of stent is a heat expandable device. This device, originally designed using NITINOL by Dotter has recently been modified to a new tin-coated, heat expandable coil by Regan. The stent is delivered to the affected area on a catheter capable of receiving heated fluids. Once properly positioned, heated saline is passed through the portion of the catheter on which the stent is located, causing the stent to expand. Numerous difficulties have been encountered with this device, including difficulty in obtaining reliable expansion, and difficulties in maintaining the stent in its expanded state.
  • [0010]
    Perhaps the most popular stent presently under investigation in the United States is referred to as the Palmaz stent. The Palmaz stent involves what may be thought of a stainless steel cylinder having a number of slits in its circumference, resulting in a mesh when expanded. The stainless steel cylinder is delivered to the affected area by means of a balloon catheter, and is then expanded to the proper size by inflating the balloon.
  • [0011]
    Significant difficulties have been encountered with all prior art stents. Each has its percentage of thrombosis, restenosis and tissue in-growth, as well as varying degrees of difficulty in deployment. Another difficulty with at least some of prior art stents is that they do not readily conform to the vessel shape. In addition, the relatively long length of such prior art stents has made it difficult to treat curved vessels, and has also effectively prevented successful implantation of multiple such stents. Anticoagulants have historically been required at least for the first three months after placement. These and other complications have resulted in a low level of acceptance for such stents within the medical community, and to date stents have not been accepted as a practical method for treating chronic restenosis.
  • [0012]
    Thus there has been a long felt need for a stent which is effective to maintain a vessel open, without resulting in significant thrombosis, which may be easily delivered to the affected area, easily expanded to the desired size, easily conformed to the affected vessel, and easily used in multiples to treat curved vessels and varying lengths of lesions.
  • SUMMARY OF THE INVENTION
  • [0013]
    The present invention substantially reduces the complications and overcomes the limitations of the prior art devices. The endovascular support device of the present invention comprises a device having very low mass which is capable of being delivered to the affected area by means of a slightly modified conventional balloon catheter similar to that used in a standard balloon angioplasty procedure.
  • [0014]
    The support device of the present invention may then be expanded by normal expansion of the balloon catheter used to deliver the stent to the affected area, and its size can be adjusted within a relatively broad range in accordance with the diagnosis of the treating physician.
  • [0015]
    Because of the range of diameters through which the support device of the present invention may be expanded, it may be custom expanded to the specific lesion diameter, and is readily conformable to the vessel shape. In addition, a plurality of support devices of the present invention may be readily implanted in a number commensurate with the length of the lesion under treatment. As a result, curved or “S” shaped vessels may be treated.
  • [0016]
    The stent, or endovascular support device, of the present invention may preferably be comprised of implantable quality high grade stainless steel, machined specially for intravascular applications. The support device may comprise, in effect, a metal circle or ellipsoid formed to create a plurality of axial bends, thereby permitting compression of the stent onto a delivery catheter, and subsequent expansion once in place at the affected area.
  • [0017]
    It is one object of the present invention to provide a stent which substantially overcomes the limitations of the prior art.
  • [0018]
    It is a further object of the present invention to provide a stent capable of being implanted simply and reliably.
  • [0019]
    Another object of the present invention is to provide a stent which does not result in significant thrombosis at the point of implant.
  • [0020]
    Yet another object of the present invention is to provide a stent which can be selectively sized in accordance with the anatomic configuration dictated by the lesion itself.
  • [0021]
    A still further object of the present invention is to provide a method for supplying an endovascular support device which permits a plurality of such devices to be implanted commensurate with the length of the lesion under treatment.
  • [0022]
    These and other objects of the present invention can be better appreciated from the following detailed description of the invention, taken in conjunction with the attached drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0023]
    FIG. 1 shows a perspective view of an endovascular support device constructed according to the present invention, in its expanded form.
  • [0024]
    FIG. 2 shows a support device constructed according to the present invention and compressed onto a balloon catheter.
  • [0025]
    FIG. 3 shows support device compressed onto a balloon catheter as shown in FIG. 2, and positioned within a sectioned portion of an affected area of a artery or other vessel.
  • [0026]
    FIG. 4 shows a support device according to the present invention in its expanded form within a sectioned portion of a vessel including a lesion.
  • [0027]
    FIG. 5 shows a support device of the present invention in its expanded form within a sectioned portion of a lesion after removal of the balloon catheter.
  • [0028]
    FIG. 6 a-b show alternative configurations of a support device according to the present invention.
  • DETAILED DESCRIPTION
  • [0029]
    Referring first to FIG. 1, an endovascular support device 10, referred to hereinafter more conveniently as a stent, constructed in accordance with the present invention can be seen in perspective view. The stent 10 of FIG. 1 is shown in its expanded form, prior to compression over a suitable delivery system as discussed in detail hereinafter.
  • [0030]
    In a preferred embodiment, the stent 10 comprises a single piece of material, bent to form a plurality of upper axial turns 12 and lower axial turns 14. In the embodiment shown in FIG. 1, four upper turns 12 are connected to the four lower turns 14 by substantially straight segments 16. The axial turns 12 and 14 can be seen to permit the stent 10 to be compressed or expanded over a wide range while still maintaining significant mechanical force, such as required to prevent a vessel from restenosing. While a preferred embodiment comprises a single piece of material, in some instances a suitably welded wire may be acceptable.
  • [0031]
    It will be appreciated that the number of turns 12 and 14 can vary over a reasonably wide range, and may in fact vary between two and ten such turns or peaks. However, it is currently believed that the optimum number of turns or peaks will range between three and five for most applications, and particularly for cardiovascular applications.
  • [0032]
    The stent 10 is preferably constructed of implantable materials having good mechanical strength. An embodiment which has proven successful in preliminary testing is machines from 316LSS implantable quality stainless steel bar stock. The bar stock is machined to form substantially a toroid, which is then acid etched in phosphoric and sulfuric acid at approximately 180 to 185 to break the edges. The etched toroid is then plated with copper to avoid galling and to provide lubricity.
  • [0033]
    The copper plated toroid is then bent to the shape of the stent 10 shown in FIG. 1, after which the copper plating is stripped from the stent. The stent is then returned to the acid bath to reduce the wire size to the desired diameter, which is in the range of 0.002″ to 0.025.″ It is presently believed that the optimum wire size for the final product is in the range of 0.008″ to 0.009.″ It will be appreciated that the strength of the stent—that is, its ability to prevent restenosis—is inversely proportional to the number of peaks or turns in the stent, so that stents having a greater number of turns will typically be formed of larger wire diameters. Finally although not required in all cases, the outside of the stent may be selectively plated with platinum to provide improved visibility during fluoroscopy. The cross-sectional shape of the finished stent may be circular, ellipsoidal, rectangular, hexagonal, square, or other polygon, although at present it is believed that circular or ellipsoidal may be preferable.
  • [0034]
    The minimum length of the stent, or the distance between the upper turns 12 and lower turns 14, is determined in large measure by the size of the vessel into which stent will be implanted. The stent 10 will preferably be of sufficient length as to maintain its axial orientation within the vessel without shifting under the hydraulics of blood flow (or other fluid flow in different types of vessels), while also being long enough to extend across at least a significant portion of the affected area. At the same time, the stent should be short enough as to not introduce unnecessarily large amounts of material as might cause undue thrombosis. Typical cardiovascular vessels into which the stent 10 might be implanted range from 1.5 millimeters to five millimeters in diameter, and corresponding stents may range from one millimeter to two centimeters in length. However, in most instances the stent will range in length between 3.5 millimeters and 6 millimeters. Preliminary testing of stents having a length between 3.5 millimeters and 4.5 millimeters has been performed with good success outside the United States, and testing on animals is also ongoing.
  • [0035]
    Once the wire size of the stent 10 has been reduced to the desired size, the stent 10 may be crimped onto a balloon 100, as shown in FIG. 2, for delivery to the affected region 102 of a vessel 104 such as a coronary artery. For the sake of simplicity, the multiple layers of the vessel wall 104 are shown as a single layer, although it will be understood by those skilled in the art that the lesion typically is a plaque deposit within the intima of the vessel 104.
  • [0036]
    One suitable balloon for delivery of the stent 10 is manufactured by Advanced Cardiovascular Systems, Inc., of Santa Clara, Calif. (“ACS”), and is eight millimeters in length with Microglide on the shaft only. The stent-carrying balloon 100 is then advanced to the affected area and across the lesion 102 in a conventional manner, such as by use of a guide wire and a guide catheter (not shown). A suitable guide wire is the 0.014″ Hi Torque Floppy manufactured by ACS, and a suitable guiding catheter is the ET.076 lumen guide catheter, also manufactured by ACS.
  • [0037]
    Once the balloon 100 is in place across the lesion 102, as shown in FIG. 3, the balloon 100 may be inflated, again substantially in a conventional manner. In selecting a balloon, it is helpful to ensure that the balloon will provide radially uniform inflation so that the stent 10 will expand equally along each of the peaks. The inflation of the balloon 100, shown in FIG. 4, causes the expansion of the stent 10 from its crimped configuration back to a shape substantially like that shown in FIG. 1. The amount of inflation, and commensurate amount of expansion of the stent 10, may be varied as dictated by the lesion itself, making the stent of the present invention particularly flexible in the treatment of chronic restenosis.
  • [0038]
    Because of the inflation of the balloon, the lesion 102 in the vessel 104 is expanded, and causes the arterial wall of the vessel 104 to bulge radially, as simplistically depicted in FIG. 4. At the same time, the plaque deposited within the intima of the vessel is displaced and thinned, and the stent 10 is embedded in the plaque or other fibrotic material adhering to the intima of the vessel 104.
  • [0039]
    Following inflation of the balloon 100 and expansion of the stent 10 within the vessel 104, the balloon is deflated and removed. The exterior wall of the vessel 104 returns to its original shape through elastic recoil. The stent 10, however, remains in its expanded form within the vessel, and prevents further restenosis of the vessel. The stent maintains an open passageway through the vessel, as shown in FIG. 4, so long as the tendency toward restenosis is not greater than the mechanical strength of the stent 10. Because of the low mass of the support device 10 of the present invention, thrombosis is less likely to occur. Ideally, the displacement of the plaque deposits and the implantation of the stent 10 will result in a smooth inside diameter of the vessel 104, although this ideal cannot be achieved in all cases.
  • [0040]
    One advantages of the stent 10 is that multiple stents may be used in the treatment of a single lesion. Thus, for example, in the event the affected area shown in FIGS. 3 and 4 was longer than the stent 10, additional stents 10 could be positioned elsewhere along the lesion to prevent restenosis. In preliminary testing, up to four stents have been used successfully along a single lesion. Due to the conformability of the stent 10, not only can varying lesion lengths be treated but curved vessels and “S” shaped vessels may also be treated by the present invention. In instances where it is known in advance that multiple stents will be the preferred method of treatment, a plurality of such stents may be positioned along a single balloon catheter for simultaneous delivery to the affected area.
  • [0041]
    As discussed above, the number of peaks or turns 12 and 14 in the stent 10 may vary between two and ten. To this end, shown in FIGS. 6 a and 6 b are two alternative configurations of the stent 10. The alternative embodiment shown in 6 a can be seen to have three upper and three lower peaks or turns, while the embodiment shown in FIG. 6 b can be seen to have ten upper and ten lower peaks.
  • [0042]
    While the primary application for the stent 10 is presently believed to be treatment of cardiovascular disease such as atherosclerosis or other forms of coronary narrowing, the stent 10 of the present invention may also be used for treatment of narrowed vessels in the kidney, leg, carotid, or elsewhere in the body. In such other vessels, the size of the stent may need to be adjusted to compensate for the differing sizes of the vessel to be treated, bearing in mind the sizing guidelines provided above.
  • [0043]
    Having fully described a preferred embodiment of the invention, those skilled in the art will immediately appreciate, given the teachings herein, that numerous alternatives and equivalents exist which do not depart from the present invention. It is therefore to be understood that the present invention is not to be limited by the foregoing description, but only by the appended claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2070073 *23 Jul 19359 Feb 1937Burgess Lab Inc C FFilter
US2701559 *2 Aug 19518 Feb 1955Cooper William AApparatus for exfoliating and collecting diagnostic material from inner walls of hollow viscera
US3562820 *21 Aug 196716 Feb 1971Bernhard BraunTubular sheet and strip form prostheses on a basis of biological tissue
US3657744 *8 May 197025 Apr 1972Univ MinnesotaMethod for fixing prosthetic implants in a living body
US3713175 *19 Nov 197030 Jan 1973HowmedicaMetal alloy cardiovascular implant device
US3714671 *30 Nov 19706 Feb 1973Cutter LabTissue-type heart valve with a graft support ring or stent
US3858441 *12 Jul 19737 Jan 1975Comeau Henri JulesSoil testing apparatus
US3868956 *5 Jun 19724 Mar 1975Ralph J AlfidiVessel implantable appliance and method of implanting it
US3874388 *12 Feb 19731 Apr 1975Ochsner Med Found AltonShunt defect closure system
US3882845 *17 Dec 197313 May 1975Investors In Ventures IncMethods and devices for reducing lumen constriction
US3952747 *28 Mar 197427 Apr 1976Kimmell Jr Garman OFilter and filter insertion instrument
US4065816 *12 Nov 19763 Jan 1978Philip Nicholas SawyerSurgical method of using a sterile packaged prosthesis
US4076285 *1 Aug 197528 Feb 1978Erika, Inc.Laminar flow connector for conduits
US4080706 *4 Nov 197628 Mar 1978Medrad, Inc.Method of manufacturing catheter guidewire
US4140126 *18 Feb 197720 Feb 1979Choudhury M HasanMethod for performing aneurysm repair
US4183103 *29 Jun 197815 Jan 1980Eric BlochProsthetic one-way heart valve
US4190909 *31 Mar 19784 Mar 1980Ablaza Sariel G GApparatus and method for surgical repair of dissecting thoracic aneurysms and the like
US4195637 *21 Nov 19771 Apr 1980Schneider Medintag AgCatheter arrangement, method of catheterization, and method of manufacturing a dilatation element
US4198982 *31 Mar 197822 Apr 1980Memorial Hospital For Cancer And Allied DiseasesSurgical stapling instrument and method
US4313231 *30 Oct 19802 Feb 1982Kabushiki Kaisha Tatebe SeishudoVascular prosthesis
US4319363 *23 May 197916 Mar 1982Vettivetpillai KetharanathanVascular prostheses
US4328811 *28 Jul 198011 May 1982Fogarty Thomas JCalibrating dilation catheter
US4448195 *8 May 198115 May 1984Leveen Harry HReinforced balloon catheter
US4493711 *25 Jun 198215 Jan 1985Thomas J. FogartyTubular extrusion catheter
US4497531 *19 Jul 19825 Feb 1985Amp IncorporatedElectrical connector
US4503569 *3 Mar 198312 Mar 1985Dotter Charles TTransluminally placed expandable graft prosthesis
US4512338 *25 Jan 198323 Apr 1985Balko Alexander BProcess for restoring patency to body vessels
US4562596 *25 Apr 19847 Jan 1986Elliot KornbergAortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4572186 *7 Dec 198325 Feb 1986Cordis CorporationVessel dilation
US4577631 *16 Nov 198425 Mar 1986Kreamer Jeffry WAneurysm repair apparatus and method
US4580568 *1 Oct 19848 Apr 1986Cook, IncorporatedPercutaneous endovascular stent and method for insertion thereof
US4586505 *3 May 19846 May 1986Universal Prosthetics, Inc.Laryngeal and tracheal stent
US4641653 *19 Feb 198510 Feb 1987Rockey Arthur GMedical sleeve
US4643184 *17 Apr 198417 Feb 1987Mobin Uddin KaziEmbolus trap
US4647416 *26 Apr 19853 Mar 1987Shiley IncorporatedMethod of preparing a vascular graft prosthesis
US4649922 *23 Jan 198617 Mar 1987Wiktor Donimik MCatheter arrangement having a variable diameter tip and spring prosthesis
US4650466 *1 Nov 198517 Mar 1987Angiobrade PartnersAngioplasty device
US4655771 *11 Apr 19837 Apr 1987Shepherd Patents S.A.Prosthesis comprising an expansible or contractile tubular body
US4660559 *19 Sep 198328 Apr 1987Ethicon, Inc.Sterile surgical needles with a hard sharp cutting edge and method for producing the same
US4660560 *30 May 198528 Apr 1987The Beth Israel Hospital AssociationMethod for treating obstructive prostatism
US4665918 *6 Jan 198619 May 1987Garza Gilbert AProsthesis system and method
US4723549 *18 Sep 19869 Feb 1988Wholey Mark HMethod and apparatus for dilating blood vessels
US4731054 *20 Jun 198615 Mar 1988Sulzer Brothers LimitedMedical repository probe
US4733665 *7 Nov 198529 Mar 1988Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4739762 *3 Nov 198626 Apr 1988Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4740207 *10 Sep 198626 Apr 1988Kreamer Jeffry WIntralumenal graft
US4794928 *10 Jun 19873 Jan 1989Kletschka Harold DAngioplasty device and method of using the same
US4795458 *2 Jul 19873 Jan 1989Regan Barrie FStent for use following balloon angioplasty
US4800882 *13 Mar 198731 Jan 1989Cook IncorporatedEndovascular stent and delivery system
US4813925 *21 Apr 198721 Mar 1989Medical Engineering CorporationSpiral ureteral stent
US4892539 *8 Feb 19889 Jan 1990D-R Medical Systems, Inc.Vascular graft
US4892541 *29 Jan 19879 Jan 1990Tascon Medical Technology CorporationHeart valve prosthesis
US4893623 *20 Nov 198716 Jan 1990Advanced Surgical Intervention, Inc.Method and apparatus for treating hypertrophy of the prostate gland
US4902289 *9 Aug 198820 Feb 1990Massachusetts Institute Of TechnologyMultilayer bioreplaceable blood vessel prosthesis
US4907336 *9 Sep 198813 Mar 1990Cook IncorporatedMethod of making an endovascular stent and delivery system
US4913141 *25 Oct 19883 Apr 1990Cordis CorporationApparatus and method for placement of a stent within a subject vessel
US4986831 *25 Apr 198822 Jan 1991Angeion CorporationMedical implant
US4990155 *19 May 19895 Feb 1991Wilkoff Howard MSurgical stent method and apparatus
US4994032 *29 Nov 198819 Feb 1991Terumo Kabushiki KaishaBalloon catheter
US4994071 *22 May 198919 Feb 1991Cordis CorporationBifurcating stent apparatus and method
US4994077 *21 Apr 198919 Feb 1991Dobben Richard LArtificial heart valve for implantation in a blood vessel
US4998539 *13 Dec 198812 Mar 1991Delsanti Gerard LMethod of using removable endo-arterial devices to repair detachments in the arterial walls
US4998923 *23 Dec 198812 Mar 1991Advanced Cardiovascular Systems, Inc.Steerable dilatation catheter
US5002560 *8 Sep 198926 Mar 1991Advanced Cardiovascular Systems, Inc.Expandable cage catheter with a rotatable guide
US5007926 *24 Feb 198916 Apr 1991The Trustees Of The University Of PennsylvaniaExpandable transluminally implantable tubular prosthesis
US5078726 *9 Apr 19907 Jan 1992Kreamer Jeffry WGraft stent and method of repairing blood vessels
US5078736 *4 May 19907 Jan 1992Interventional Thermodynamics, Inc.Method and apparatus for maintaining patency in the body passages
US5084065 *10 Jul 198928 Jan 1992Corvita CorporationReinforced graft assembly
US5089005 *8 Feb 199018 Feb 1992Terumo Kabushiki KaishaCatheter for the introduction of an expandable member
US5089006 *29 Nov 198918 Feb 1992Stiles Frank BBiological duct liner and installation catheter
US5092877 *5 Jul 19903 Mar 1992Corvita CorporationRadially expandable endoprosthesis
US5102417 *28 Mar 19887 Apr 1992Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5104399 *9 Mar 198814 Apr 1992Endovascular Technologies, Inc.Artificial graft and implantation method
US5104404 *20 Jun 199114 Apr 1992Medtronic, Inc.Articulated stent
US5108416 *13 Feb 199028 Apr 1992C. R. Bard, Inc.Stent introducer system
US5108417 *14 Sep 199028 Apr 1992Interface Biomedical Laboratories Corp.Anti-turbulent, anti-thrombogenic intravascular stent
US5192307 *5 Feb 19929 Mar 1993Wall W HenryAngioplasty stent
US5195984 *19 Feb 199123 Mar 1993Expandable Grafts PartnershipExpandable intraluminal graft
US5201901 *7 Oct 198813 Apr 1993Terumo Kabushiki KaishaExpansion unit and apparatus for expanding tubular organ lumen
US5275622 *13 Jul 19904 Jan 1994Harrison Medical Technologies, Inc.Endovascular grafting apparatus, system and method and devices for use therewith
US5282824 *15 Jun 19921 Feb 1994Cook, IncorporatedPercutaneous stent assembly
US5282849 *19 Dec 19911 Feb 1994University Of Utah Research FoundationVentricle assist device with volume displacement chamber
US5292331 *24 Aug 19898 Mar 1994Applied Vascular Engineering, Inc.Endovascular support device
US5306286 *1 Feb 199126 Apr 1994Duke UniversityAbsorbable stent
US5382261 *1 Sep 199217 Jan 1995Expandable Grafts PartnershipMethod and apparatus for occluding vessels
US5383892 *6 Nov 199224 Jan 1995Meadox FranceStent for transluminal implantation
US5397345 *29 Dec 199314 Mar 1995Endovascular Technologies, Inc.Artificial graft and implantation method
US5507767 *15 Jan 199216 Apr 1996Cook IncorporatedSpiral stent
US5507768 *6 Jul 199316 Apr 1996Advanced Cardiovascular Systems, Inc.Stent delivery system
US5507771 *24 Apr 199516 Apr 1996Cook IncorporatedStent assembly
US5591197 *14 Mar 19957 Jan 1997Advanced Cardiovascular Systems, Inc.Expandable stent forming projecting barbs and method for deploying
US5591198 *27 Apr 19957 Jan 1997Medtronic, Inc.Multiple sinusoidal wave configuration stent
US5618299 *8 Aug 19958 Apr 1997Advanced Cardiovascular Systems, Inc.Ratcheting stent
US5618301 *19 Jan 19968 Apr 1997Angiomed AgReducing stent, device with reducing stent and use of a reducing stent
US5879382 *30 Apr 19979 Mar 1999Boneau; Michael D.Endovascular support device and method
US5891190 *6 Jun 19956 Apr 1999Boneau; Michael D.Endovascular support device and method
US6344053 *5 Apr 19995 Feb 2002Medtronic Ave, Inc.Endovascular support device and method
Classifications
U.S. Classification623/1.15
International ClassificationA61F2/86, A61F2/00
Cooperative ClassificationA61F2/86, A61F2210/0042
European ClassificationA61F2/86
Legal Events
DateCodeEventDescription
1 Mar 2005ASAssignment
Owner name: MEDTRONIC VASCULAR, INC., CALIFORNIA
Free format text: CHANGE OF NAME;ASSIGNOR:MEDTRONIC AVE, INC.;REEL/FRAME:015714/0467
Effective date: 20030908